Observational studyJournal of diabetes investigation2021

Beneficial effects of switching to denosumab from bisphosphonates or selective estrogen receptor modulators in postmenopausal women with type 2 diabetes and osteopenia/osteoporosis.

Arina Miyoshi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.